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Having Diabetes in a Middle-Income Country 
Diego Carrion Alvarez,1 Nallely Alejandra Obregon Perales.1 
The Experience 
In our university, we started clinical rotations in family medicine. For 
six months, we learned how to diagnose and treat patients from all 
socioeconomic classes. However, some cases had an impact on us. A 
lady in her late 60’s came for her routine diabetes check-up. She had 
been diagnosed just three months ago; currently, she was taking 
metformin and trying to improve her lifestyle. Her lab tests results were 
still above the recommended values. Our doctor invited us to ask her 
about her habits and diet. She did not exercise; furthermore, the 
nutritionist recommended her a Mediterranean diet. We suggested the 
idea of starting insulin if her lab results persisted. Her answer shocked 
us: “Doctors, how am I supposed to change my diet? The plan provided 
by the nutritionist includes fish and olive oil. I barely have money to 
buy a few eggs, beans and tortillas, and eat chicken or meat only when 
possible. Even more, I doubt I could afford the syringes and the needles 
for the insulin injections.” Our tutor recommended small diet changes 
and increased the metformin dose. The patient was discharged with a 
new appointment to review her glucose values. Upon this scenario, we 
learned what it is like to have a chronic disease as a low-income patient 
in a middle-income country. 
 
Health and Economics 
In Mexico, diabetes represents a significant health problem. The current 
lifestyle, dietary habits, and an alarming increase in obesity rates are 
just the tip of an underlying issue. In 2012, diabetes prevalence was 
around 8.9%. However, prospective studies expect it to grow to 22.6% 
by 2050, meaning that almost one in every three Mexicans will suffer 
from the disease.1 The picture in Latin America is similar since the 
prevalence of diabetes has increased by 9% from 2014 to 2016.2 In a 
country like Mexico, where according to the World Bank 3.2 million 
inhabitants live with less than 1.90 USD a day and 44.4 million struggle 
to survive with less than 5.50 USD, it can be difficult to change your 
lifestyle. Diabetes is a multifactorial disease, and even though poverty 
plays a significant role in its development, other factors such as 
governmental policies addressing unhealthy food and encouraging 
early lifestyle changes contribute to the big picture. These factors are 
mentioned in Figure 1 and need to be considered when outlining the 
correct public health approach to the problem.3 Low-income 
populations tend to have worse outcomes and so they need to be 
targeted by health institutions.4 
 
The Cost of Diabetes 
Diabetes is one of the most prevalent diseases worldwide. It is a chronic 
disorder and requires strict control. In 2015, the economic burden of 
diabetes was estimated at 1.3 trillion USD globally and is estimated to 
increase up to 2.2 trillion USD by 2030; furthermore, even if countries 
meet international targets, that will not reduce the burden of the 
disease.2 Latin American healthcare systems absorb part of the 
economic charge by providing medical appointments, lab tests and 
certain medications. However, due to the huge amount of patients and 
the lack of resources, they are unable to afford the newest medication 
available, relying on cheaper drug options. Polypharmacy is an 
important part of diabetes management, and since not all drugs are 
available, some patients may be unable to reach therapeutic goals, 
presenting complications or switching to insulin-based treatments.5 
Healthcare systems also cover the costs of complications such as 
neuropathy, retinopathy, nephropathy or limb amputation; these are 
all complications that impact negatively on the economy taking out of 
the workforce otherwise productive individuals. Even with these 
systems, diabetes still represents a cost for the patient; changing to a 
healthier lifestyle and buying syringes and needles is a patient’s 
responsibility, as well as the acquisition of a glucometer, lancets and 
paper strips for proper self-management. 
 
What can students do? 
It is said that each individual is a world; the personalization of 
treatment in middle income countries needs to start. Mexican 
guidelines are outdated, and they stick to the recommendations of the 
American Diabetes Association (ADA) without considering the 
differences in our countries healthcare systems, social structure, and 
economic capabilities. An example of a more personalized adaptation 
can be found in the 2018 consensus between the ADA and the European 
Association for the Study of Diabetes (EASD) since in this guideline 
policymakers do contemplate medicine costs.6 However, contexts are 
unique to each country and they even vary between regions; Mexican 
health authorities, such as the “Centro Nacional de Excelencia 
Tecnológica en Salud”, need to change their approach and focus the 
attention of protocols also on treatment individualization based on 
economic status and even the patients’ cooperation. As students, it is 
our duty to demand better healthcare options for our patients by 
pushing governmental institutions to shift to a more personalized care 
and ensure that preventive health policies may endure. 
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Figure 1. Risk Factors associated with the Development of Type II Diabetes Mellitus. 
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